Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2018        Go!    
 
 
May 24, Thursday 2018 5:46 AM       

       HEADLINES: Actor Vijayan Peringode dies                                              Efforts to resolve church dispute will continue, says Patriarch Bava                                              All party meet on May 25 in Kozhikode                                              Don't fall prey to Nipah-related rumours: Governor                                              Nipah virus outbreak: Suspended Gorakhpur doctor offers help                                              BJP MP Bandaru Dattatreya's son dies of heart attack                                              Kamal Haasan demands Sterlite industry to be shut                                              H D Kumaraswamy swears in as K'taka CM                                              Four Nepali woman journalists scale Mount Everest                                              Trump-Kim meeting set to take place on June 12: Pompeo                                              Corruption cases result of high treason case instituted against Musharraf: Sharif                                              Ode to ABD: When 360 degree was not geometry but joy                                              AFI names 51-member team for Asian Junior Athletics                                              'Tired' AB De Villiers retires from international cricket                                              Kaumudi Facebook
       SCI&TECH Next Article: Soon, you can demote group admins on WhatsApp  
       Absence of this gene can give men deadly cancer
 
         Posted on :18:33:06 Jan 18, 2018
   
A A
       Last edited on:18:33:06 Jan 18, 2018
         Tags: Absence of this gene can give men deadly canc
 

WASHINGTON DC: A study has recently revealed that men who lack a certain gene subtype may be more susceptible to treatment-resistant prostate cancer.

Researchers from Cleveland Clinic confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, aggressive prostate cancer.

The team built upon their earlier seminal work in which they discovered that a gene called HSD3B1, when altered, enables prostate tumours to evade treatment and proliferate.

They went on to show that the presence of this gene variant does in fact change treatment outcomes and overall survival in men.

Lead researcher Nima Sharifi explained that they studied a related gene, called HSD17B4.

Previous research showed that HSD17B4 encodes enzymes that inactivate androgens (male hormones).

Since androgens are essential for prostate cancer growth, inactivating them should prevent cancer advancement. But these enzymes have also been observed to be more abundant in advanced prostate cancer.

Therapy for advanced prostate cancer--called androgen deprivation therapy (ADT), or chemical castration--blocks cells' supply of androgens, which they use as fuel to grow and spread.

While ADT is successful early on, it eventually fails, allowing the cancer to progress to a lethal phase called castration-resistant prostate cancer (CRPC).

"We are hopeful that these findings will lead to more precise and effective treatments for prostate cancer", Dr. Sharifi stated.

"If men lack a specific isoform of this gene, we may be able to personalise their therapy," he explained.

To determine HSD17B4's role in the transition to CRPC, the researhers analysed its expression in tissue from patients with healthy prostates, localised prostate cancer and CRPC.

They found that HSD17B4 expression levels were relatively the same in benign and local prostate cancer tissue, but significantly reduced in CRPC tissue, suggesting that HSD17B4 does play a role in preventing progression to CRPC.

The findings indicated that only one specific isoform of HSD17B4--isoform 2--enzymatically inactivated androgens and prevented tumour growth.

Their findings suggest that lack of isoform 2 leads to advanced CRPC.

The research appeared in the journal Cell Reports.

A A
       SCI&TECH
Next Article: Soon, you can demote group admins on WhatsApp
 
 
SCI&TECH HEADLINES
Beat the risk of frailty with healthy heart  
Twitter to hide trolls that hurl abuse: Twitter CEO  
Fortnite is finally coming to Android  
This test could detect signs of pancreatic cancer  
Aliens exist but may be in parallel Universe: Study  
This is your heart on nitric oxide  
Is your kid's heart clock ticking right?  
Do at-risk adolescents show depressive symptoms on social media?  
NASA launches Insight spacecraft to Mars for deepest dig yet  
Daily intake of this drug can cause certain cancers in men  
A new weapon against epilepsy  
Hail stone weighing three kg sign of climate change: Expert  
PMSing? Could be because of alcohol!  
Social media firms given a week to better protect kids  
The stronger you are, the healthier your brain is  
NASA may soon identify 2,400 alien planets  
What triggers depression among adults?  
Turn your hobbies into part-time job opportunities with these apps  
Apple launches special RED Edition for iPhone 8, 8 Plus  
Humanity‚Äôs first flight to Sun to launch in July: NASA  
This World Health Day, let's focus on eye health  
Are babies being introduced to solid food too soon?  
New organ found in human body, could help understand spread of cancer  
Audio-enabled autoplay videos will soon be blocked on Google Chrome  
China hospital to employ AI to address doctor shortage  
 
Will GST help decrease the petrol price?
yes
 
no
 
don't know
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy